ARMPArmata Pharmaceuticals, Inc.vs its industry peers
A metric-by-metric comparison of Armata Pharmaceuticals, Inc. against SIC 2836 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ARMPThis | $109M#8 | — | — | — | — | -818.8%#16 | — | — | — | — | -39.1%#3 | 0.1%#1 |
| CHRS | $124M#1 | — | 2.0x#9 | 2.9x#6 | 59.8%#2 | 489.4%#1 | -429.5%#6 | 276.2%#3 | -351.2%#3 | — | — | — |
| HUMA | $118M#2 | — | 3.8x#12 | 58.0x#8 | — | 72.5%#5 | -5306.0%#9 | -130.6%#13 | — | — | -73.1%#7 | — |
| NMRA | $115M#3 | — | 2.6x#11 | — | — | -2.8%#10 | — | 532.2%#2 | -594.0%#4 | — | — | — |
| AVXL | $113M#4 | — | 1.0x#5 | — | — | -7.8%#11 | — | -41.2%#7 | — | — | — | — |
| OTLK | $112M#5 | — | — | 79.5x#9 | — | 17.2%#8 | -4744.3%#8 | — | -12.8%#2 | — | — | — |
| LENZ | $111M#6 | — | 0.6x#2 | 5.8x#7 | — | -65.0%#12 | -477.5%#7 | -42.8%#8 | — | — | -87.3%#10 | — |
| VYGR | $111M#7 | — | 0.7x#3 | 2.7x#5 | -49.5%#6 | -84.2%#13 | -326.6%#5 | -77.6%#11 | — | — | — | — |
| BDTX | $103M#9 | — | 1.1x#6 | 1.5x#4 | — | 132.1%#3 | 17.9%#2 | 23276.9%#1 | — | — | -54.4%#5 | — |
| ENGN | $99M#10 | 0.6x#1 | 0.4x#1 | — | — | -112.7%#14 | — | -50.9%#9 | — | — | -78.7%#9 | — |
| ATRA | $85M#11 | — | — | 0.7x#2 | -6.3%#4 | 138.3%#2 | 29.7%#1 | — | — | — | -40.2%#4 | — |
| TNYA | $84M#12 | — | 1.2x#7 | — | — | 18.5%#7 | — | -130.5%#12 | — | — | -73.7%#8 | — |
| VXRT | $80M#13 | 2.0x#2 | 1.0x#4 | 0.3x#1 | 726.7%#1 | 124.4%#4 | 7.6%#3 | 0.0%#4 | 22.5%#1 | — | -24.0%#1 | — |
| CSBR | $68M#14 | — | 17.5x#13 | 1.1x#3 | 4.4%#3 | -125.0%#15 | -1.9%#4 | -0.0%#5 | — | — | -27.6%#2 | — |
| CRDF | $66M#15 | — | 2.5x#10 | 112.0x#10 | -13.2%#5 | -0.9%#9 | -8256.3%#10 | -0.2%#6 | — | — | -63.0%#6 | — |
| CGTX | $65M#16 | — | 2.0x#8 | — | — | 30.9%#6 | — | -71.1%#10 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-11-04.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice